Viemed Healthcare (VMD) Gross Margin (2018 - 2026)

Viemed Healthcare (VMD) has reported Gross Margin for 9 consecutive years, with 57.68% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Margin fell 57.0% year-over-year to 57.68%; the trailing twelve-month figure through Jun 2026 stood at 57.47% (down 87.0% YoY), and the FY2025 full-year result was 57.52%, down 188.0% from the prior year.
• Gross Margin improved to 57.68% in Q2 2026 per VMD's latest filing, from 56.79% in the prior quarter.
• Across five years, Gross Margin topped out at 63.29% in Q4 2023 and bottomed at 56.28% in Q1 2025.
• Historically, Gross Margin has averaged 59.56% across 5 years, with a median of 59.69% in 2024.
• The sharpest annual moves came in 2023 and 2024: Gross Margin soared 224 bps in 2023, then plunged 375 bps in 2024.
• Over 5 years, Gross Margin stood at 61.04% in 2022, then advanced by 4 bps to 63.29% in 2023, then retreated by 6 bps to 59.54% in 2024, then dropped by 3 bps to 57.89% in 2025, then retreated by 0 bps to 57.68% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 57.68%, 56.79%, and 57.89% for Q2 2026, Q1 2026, and Q4 2025 respectively.